• Search Funds
  • Model Portfolios
  • Provider
  • Sector
  • Manager

Search by provider name

Search by sector name

Search by manager name

Search by Risk Level

Legal & General Global Health & Pharmaceuticals Index Trust (I) - Acc

  • Fund Info & charges
  • Performance
  • Fund breakdown
  • Dividend History
Fund Provider Legal & General(Unit Trust Managers)Ltd
Fund Summary The objective of this fund is to provide growth by tracking the performance of those companies in the FTSE World Index which are engaged in Health, Pharmaceuticals and Biotechnology activities.
SEDOL code B0CNH38
ISIN GB00B0CNH387
Fund code LGGPA
Managers Not Disclosed
Manager Tenure 7 years
Morningstar Category Sector Equity Healthcare
IMA Sector Global
Fund Size £469 million
Fund Type OEIC
Management Style Passive
Ongoing Charge Figure (OCF) 0.31%
Cavendish ongoing charge 0.05%
FundsNetwork Service Fee 0.20%
Minimum Initial Investment £25
Minimum Top Up £25
Minimum Monthly Investment £25
Sell Price £0.8384
Buy Price £0.8401
Price Date 27th March 2020
Yield 1.40%
Dividend Frequency Yearly
ISA Eligible Yes
SIPP Eligible Yes
Inception Date 20th May 2013
Fund Status OPEN

3-year Mean Monthly Return: 0.631%

Annual Returns 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Fund Performance +18.83% +7.37% +10.02% +12.29% +12.26% +26.32% +32.62% +12.22% +10.02% +5.85%
Benchmark Performance
(Sector Equity Healthcare)
+17.02% +2.70% +9.96% +7.35% +11.40%
Time Period Cumulative Benchmark Performance
(Sector Equity Healthcare)
Fund Compared to Benchmark
1 day -1.68% -8.15% +6.47%
1 week 0.10% -7.71% +7.81%
1 month -6.66% -9.48% +2.82%
3 months -9.99% -2.81% -7.18%
6 months -3.37% +1.28% -4.65%
1 year 3.94% +4.39% -0.45%
3 years 6.60% +5.32% +1.28%
5 years 7.38% +10.54% -3.16%
10 years 12.39% +5.89% +6.50%
YTD -8.93% +1.66% -10.59%
Since inception 6.44% Currently unavailable Currently unavailable

Top 10 shares for this fund

Share Name Country Value
Johnson & Johnson USA 7.13%
UnitedHealth Group Inc USA 4.68%
Roche Holding AG Dividend Right Cert. CHE 4.23%
Merck & Co Inc USA 3.94%
Pfizer Inc USA 3.73%
Novartis AG CHE 3.59%
Medtronic PLC USA 2.83%
Abbott Laboratories USA 2.75%
Bristol-Myers Squibb Company USA 2.66%
AstraZeneca PLC GBR 2.32%
Dividend Date Per share amount Reinvestment Price
8th January 2020 0.0125 £0.9267
8th January 2019 0.0113 £0.7939
8th January 2018 0.0104 £0.7341
9th January 2017 0.0096 £0.6802